Social isolation negatively impacts bone health in mice

FHS
June 18, 2023
5:20 pm

Social isolation may negatively impact bone health, suggests a study conducted in mice being presented Sunday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.

PE Firm Thoma Bravo Makes Strategic Investment in Bluesight & Medacist Acquisition

What You Should Know: – Today Thoma Bravo, a private equity software investment firm, announced a strategic growth investment in Bluesight, the Medication Intelligence™ Company.

July 17, 2023

Inventiva secures up to $380m for MASH treatment lanifibranor – Pharmaceutical Technology

The FDA approved the first treatment for MASH in March this year. Image credit: Shutterstock/ Iurii Motov. Inventiva has secured up to €348m ($380m) in

October 14, 2024

Drug-coated balloon shows superiority in coronary in-stent restenosis treatment

In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel

March 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.